• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . Clinical Characteristics of COVID-19 Patients and Application to an Artificial Intelligence System for Disease Surveillance

tetano

Editor, Senior Moderator
J Clin Med


. 2022 Mar 5;11(5):1437.
doi: 10.3390/jcm11051437.
Clinical Characteristics of COVID-19 Patients and Application to an Artificial Intelligence System for Disease Surveillance


Ying-Chuan Wang[SUP] 1 [/SUP], Dung-Jang Tsai[SUP] 2 3 [/SUP], Li-Chen Yen[SUP] 4 [/SUP], Ya-Hsin Yao[SUP] 5 [/SUP], Tsung-Ta Chiang[SUP] 6 [/SUP], Chun-Hsiang Chiu[SUP] 6 [/SUP], Te-Yu Lin[SUP] 6 [/SUP], Kuo-Ming Yeh[SUP] 6 [/SUP], Feng-Yee Chang[SUP] 6 [/SUP]



Affiliations

Abstract

During the coronavirus disease (COVID-19) pandemic, we admitted suspected or confirmed COVID-19 patients to our isolation wards between 2 March 2020 and 4 May 2020, following a well-designed and efficient assessment protocol. We included 217 patients suspected of COVID-19, of which 27 had confirmed COVID-19. The clinical characteristics of these patients were used to train artificial intelligence (AI) models such as support vector machine (SVM), decision tree, random forest, and artificial neural network for diagnosing COVID-19. When analyzing the performance of the models, SVM showed the highest sensitivity (SVM vs. decision tree vs. random forest vs. artificial neural network: 100% vs. 42.86% vs. 28.57% vs. 71.43%), while decision tree and random forest had the highest specificity (SVM vs. decision tree vs. random forest vs. artificial neural network: 88.37% vs. 100% vs. 100% vs. 94.74%) in the diagnosis of COVID-19. With the aid of AI models, physicians may identify COVID-19 patients earlier, even with few baseline data available, and segregate infected patients earlier to avoid hospital cluster infections and to ensure the safety of medical professionals and ordinary patients in the hospital.

Keywords: COVID-19; artificial intelligence; artificial neural network; decision tree; random forest; support vector machine (SVM).
 
Back
Top Bottom